Overview

Bipolar Depression and Inflammation

Status:
Completed

Trial end date:
2019-03-01

Target enrollment:

Participant gender:

Summary

This project will attempt to enhance and augment the antidepressant efficacy of a commonly used antidepressant in poorly responding bipolar depressed patients.

Phase:

Phase 4

Details

Lead Sponsor:

Loyola University

Collaborator:

Stanley Medical Research Institute

Treatments:

Celecoxib
Citalopram
Cyclooxygenase 2 Inhibitors
Dexetimide